Dr Reddy’s Laboratories (RDY) has released an update.
Dr. Reddy’s Laboratories Ltd. has received a tax demand order from the GST Authority, including interest and penalties, with the appellate authority upholding a previous decision relating to credit availment in GST returns. The company, which is listed on multiple stock exchanges, announced the financial impact of the order is not material and is considering an appeal against the decision.
For further insights into RDY stock, check out TipRanks’ Stock Analysis page.
